Studieoverzicht

 
 
 
  2022-05 EMBER-4       Open       Adjuvant       HER2- HR+       Both pre- and postmenopausal  
  2022-04 NABOR       Open       Data registration       Any HER2, any HR       Both pre- and postmenopausal  
  2022-03 ALPHABET       Open       Advanced/metastatic       HER2+, any HR       Both pre- and postmenopausal  
  2022-02 DESCARTES       Open       Locoregional       Any HER2, any HR       Both pre- and postmenopausal  
  2021-01 SEQUEL-Breast       Open       Advanced/metastatic       HER2- HR+       Both pre- and postmenopausal  
  2014-04 LORD       Open       Locoregional       Not applicable       Both pre- and postmenopausal